Jonathan D Root
11 additional roles and seats, 22 additional attributed investments
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 1 deal12 months
1 investment attributed in the last 12 months;
A partner with a recent deal is actively writing cheques now.
Roles
- U.S. Venture Partners Managing MemberNov 1, 2004 to present · “Schedule A: ROOT, JONATHAN, D, MANAGING MEMBER, since 11/2004, ownership B, control person Y”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Okami Medical, Inc. | Form D equity offering · $28.9M | U.S. Venture Partners | strongly supported · board | Dec 1, 2025 | Inference sec.gov |
| Sparrow Pharmaceuticals, Inc. | Form D equity offering · $61.8M | U.S. Venture Partners | strongly supported · board | Jul 1, 2025 | Inference sec.gov |
| Okami Medical, Inc. | Form D equity offering · $18.6M | U.S. Venture Partners | strongly supported · board | Sep 6, 2024 | Inference sec.gov |
Board seats and vehicles
- Okami Medical, Inc. board seat on a deal Dec 1, 2025 Inference
- Sparrow Pharmaceuticals, Inc. board seat on a deal Jul 1, 2025 Inference
- Route 92 Medical, Inc. board seat on a deal Jul 12, 2024 Inference
- U.S. Venture Partners XIV, L.P. Executive Officer Jul 31, 2026
- U.S. Venture Partners Xi, L.P. Executive Officer Sep 19, 2014
- U.S. Venture Partners Xii, L.P. Executive Officer Mar 28, 2018
Timeline
- Dec 1, 2025Form D equity offering in Okami Medical, Inc. (U.S. Venture Partners)
- Jul 1, 2025Form D equity offering in Sparrow Pharmaceuticals, Inc. (U.S. Venture Partners)
- Sep 6, 2024Form D equity offering in Okami Medical, Inc. (U.S. Venture Partners)
- Nov 1, 2004Joined U.S. Venture Partners as Managing Member